Cargando…
Prognostic and clinical significance of HER-2 low expression in early-stage gastric cancer
INTRODUCTION: Gastric cancer is the most fifth common tumor worldwide. Human epidermal growth factor receptor 2 (HER2) overexpression is associated with poor prognosis and clinical characteristics in gastric cancer. Nevertheless, the biology of HER2-low expression has not reported in gastric cancer....
Autores principales: | Yang, Tao, Xu, Rui, You, Junhao, Li, Fang, Yan, Bing, Cheng, Jia-nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652852/ https://www.ncbi.nlm.nih.gov/pubmed/36371187 http://dx.doi.org/10.1186/s12885-022-10262-7 |
Ejemplares similares
-
The Prognostic Significance of Her2-Neu Over expression in Gastric Carcinomas
por: Ansari, J, et al.
Publicado: (2011) -
HER-2 Expression in Immunohistochemistry Has No Prognostic Significance in Gastric Cancer Patients
por: Halon, Agnieszka, et al.
Publicado: (2012) -
The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature
por: Lei, Yu-ying, et al.
Publicado: (2017) -
Clinicopathologic characteristics and prognostic significance of HER2-low expression in patients with early breast cancer: A systematic review and meta-analysis
por: Wei, Tong, et al.
Publicado: (2023) -
Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas
por: Kountourakis, Panteleimon, et al.
Publicado: (2006)